Literature DB >> 15514418

Functional neuroimaging evidence for hyperarousal in insomnia.

Eric A Nofzinger1, Daniel J Buysse, Anne Germain, Julie C Price, Jean M Miewald, David J Kupfer.   

Abstract

OBJECTIVE: The authors investigated the neurobiological basis of poor sleep and daytime fatigue in insomnia.
METHOD: [(18)F]Fluorodeoxyglucose positron emission tomography was used to assess regional cerebral glucose metabolism of seven patients with insomnia and 20 healthy subjects.
RESULTS: Compared with healthy subjects, patients with insomnia showed greater global cerebral glucose metabolism during sleep and while awake, a smaller decline in relative metabolism from waking to sleep states in wake-promoting regions, and reduced relative metabolism in the prefrontal cortex while awake.
CONCLUSIONS: Subjectively disturbed sleep in patients with insomnia is associated with greater brain metabolism. The inability to fall asleep may be related to a failure of arousal mechanisms to decline in activity from waking to sleep states. Further, daytime fatigue may reflect decreased activity in the prefrontal cortex resulting from inefficient sleep.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15514418     DOI: 10.1176/appi.ajp.161.11.2126

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  215 in total

1.  Enhanced frontoparietal synchronized activation during the wake-sleep transition in patients with primary insomnia.

Authors:  María Corsi-Cabrera; Pedro Figueredo-Rodríguez; Yolanda del Río-Portilla; Jorge Sánchez-Romero; Lídice Galán; Jorge Bosch-Bayard
Journal:  Sleep       Date:  2012-04-01       Impact factor: 5.849

2.  The role of GABA in primary insomnia.

Authors:  David T Plante; J Eric Jensen; John W Winkelman
Journal:  Sleep       Date:  2012-06-01       Impact factor: 5.849

3.  Neural correlates of working memory performance in primary insomnia.

Authors:  Sean P A Drummond; Matthew Walker; Erin Almklov; Manuel Campos; Dane E Anderson; Laura D Straus
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

4.  EEG sleep spectra in older adults across all circadian phases during NREM sleep.

Authors:  Mirjam Münch; Edward J Silva; Joseph M Ronda; Charles A Czeisler; Jeanne F Duffy
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

5.  Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?

Authors:  David T Plante; J Eric Jensen; Laura Schoerning; John W Winkelman
Journal:  Neuropsychopharmacology       Date:  2012-02-08       Impact factor: 7.853

6.  Increased use-dependent plasticity in chronic insomnia.

Authors:  Rachel E Salas; Joseph M Galea; Alyssa A Gamaldo; Charlene E Gamaldo; Richard P Allen; Michael T Smith; Gabriela Cantarero; Barbara D Lam; Pablo A Celnik
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

7.  Objective Sleep Assessments in Patients with Postural Tachycardia Syndrome using Overnight Polysomnograms.

Authors:  Kanika Bagai; Amanda C Peltier; Beth A Malow; André Diedrich; Cyndya A Shibao; Bonnie K Black; Sachin Y Paranjape; Carlos Orozco; Italo Biaggioni; David Robertson; Satish R Raj
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

8.  Hyperarousal in insomnia and hypnotic dose escalation.

Authors:  T A Roehrs; T Roth
Journal:  Sleep Med       Date:  2016-07-06       Impact factor: 3.492

Review 9.  Insomnia.

Authors:  Daniel J Buysse
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

10.  Sleep-Wake Differences in Relative Regional Cerebral Metabolic Rate for Glucose among Patients with Insomnia Compared with Good Sleepers.

Authors:  Daniel B Kay; Helmet T Karim; Adriane M Soehner; Brant P Hasler; Kristine A Wilckens; Jeffrey A James; Howard J Aizenstein; Julie C Price; Bedda L Rosario; David J Kupfer; Anne Germain; Martica H Hall; Peter L Franzen; Eric A Nofzinger; Daniel J Buysse
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.